Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.07
MLAB's Cash to Debt is ranked lower than
92% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.56 vs. MLAB: 0.07 )
Ranked among companies with meaningful Cash to Debt only.
MLAB' s Cash to Debt Range Over the Past 10 Years
Min: 0.05  Med: 10000.00 Max: No Debt
Current: 0.07
Equity to Asset 0.52
MLAB's Equity to Asset is ranked lower than
65% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.63 vs. MLAB: 0.52 )
Ranked among companies with meaningful Equity to Asset only.
MLAB' s Equity to Asset Range Over the Past 10 Years
Min: 0.51  Med: 0.94 Max: 0.97
Current: 0.52
0.51
0.97
F-Score: 4
Z-Score: 3.73
M-Score: -2.71
WACC vs ROIC
5.79%
8.56%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 18.72
MLAB's Operating margin (%) is ranked higher than
82% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.71 vs. MLAB: 18.72 )
Ranked among companies with meaningful Operating margin (%) only.
MLAB' s Operating margin (%) Range Over the Past 10 Years
Min: 22.24  Med: 32.16 Max: 36.1
Current: 18.72
22.24
36.1
Net-margin (%) 11.04
MLAB's Net-margin (%) is ranked higher than
74% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.63 vs. MLAB: 11.04 )
Ranked among companies with meaningful Net-margin (%) only.
MLAB' s Net-margin (%) Range Over the Past 10 Years
Min: 13.43  Med: 20.87 Max: 24.22
Current: 11.04
13.43
24.22
ROE (%) 11.36
MLAB's ROE (%) is ranked higher than
72% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.28 vs. MLAB: 11.36 )
Ranked among companies with meaningful ROE (%) only.
MLAB' s ROE (%) Range Over the Past 10 Years
Min: 13.91  Med: 18.41 Max: 22.21
Current: 11.36
13.91
22.21
ROA (%) 6.54
MLAB's ROA (%) is ranked higher than
69% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.45 vs. MLAB: 6.54 )
Ranked among companies with meaningful ROA (%) only.
MLAB' s ROA (%) Range Over the Past 10 Years
Min: 8.92  Med: 15.33 Max: 20.4
Current: 6.54
8.92
20.4
ROC (Joel Greenblatt) (%) 55.00
MLAB's ROC (Joel Greenblatt) (%) is ranked higher than
87% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.36 vs. MLAB: 55.00 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MLAB' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 60.96  Med: 71.21 Max: 83.43
Current: 55
60.96
83.43
Revenue Growth (3Y)(%) 19.50
MLAB's Revenue Growth (3Y)(%) is ranked higher than
91% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. MLAB: 19.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MLAB' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 1.2  Med: 11.30 Max: 24.7
Current: 19.5
1.2
24.7
EBITDA Growth (3Y)(%) 11.60
MLAB's EBITDA Growth (3Y)(%) is ranked higher than
62% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.60 vs. MLAB: 11.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MLAB' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 4.1  Med: 11.30 Max: 27.8
Current: 11.6
4.1
27.8
EPS Growth (3Y)(%) 4.70
MLAB's EPS Growth (3Y)(%) is ranked higher than
54% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.40 vs. MLAB: 4.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MLAB' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 1  Med: 10.80 Max: 24
Current: 4.7
1
24
» MLAB's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

MLAB Guru Trades in Q1 2015

Jim Simons 140,100 sh (-4.84%)
Chuck Royce 38,489 sh (-10.05%)
» More
Q2 2015

MLAB Guru Trades in Q2 2015

Arnold Van Den Berg 5,538 sh (New)
Chuck Royce 54,889 sh (+42.61%)
Jim Simons 134,193 sh (-4.22%)
» More
Q3 2015

MLAB Guru Trades in Q3 2015

Jim Simons 134,400 sh (+0.15%)
Arnold Van Den Berg Sold Out
Chuck Royce 49,289 sh (-10.20%)
» More
Q4 2015

MLAB Guru Trades in Q4 2015

Jim Simons 138,599 sh (+3.12%)
Chuck Royce 44,500 sh (-9.72%)
» More
» Details

Insider Trades

Latest Guru Trades with MLAB

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 34.60
MLAB's P/E(ttm) is ranked lower than
67% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.14 vs. MLAB: 34.60 )
Ranked among companies with meaningful P/E(ttm) only.
MLAB' s P/E(ttm) Range Over the Past 10 Years
Min: 10.41  Med: 17.87 Max: 47.76
Current: 34.6
10.41
47.76
Forward P/E 22.94
MLAB's Forward P/E is ranked lower than
68% of the 140 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.84 vs. MLAB: 22.94 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 34.80
MLAB's PE(NRI) is ranked lower than
62% of the 144 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.14 vs. MLAB: 34.80 )
Ranked among companies with meaningful PE(NRI) only.
MLAB' s PE(NRI) Range Over the Past 10 Years
Min: 10.41  Med: 17.87 Max: 47.97
Current: 34.8
10.41
47.97
P/B 3.71
MLAB's P/B is ranked lower than
79% of the 256 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.27 vs. MLAB: 3.71 )
Ranked among companies with meaningful P/B only.
MLAB' s P/B Range Over the Past 10 Years
Min: 1.78  Med: 3.07 Max: 5.53
Current: 3.71
1.78
5.53
P/S 3.98
MLAB's P/S is ranked lower than
87% of the 256 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.86 vs. MLAB: 3.98 )
Ranked among companies with meaningful P/S only.
MLAB' s P/S Range Over the Past 10 Years
Min: 2.32  Med: 3.91 Max: 6.77
Current: 3.98
2.32
6.77
PFCF 33.49
MLAB's PFCF is ranked lower than
64% of the 167 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.49 vs. MLAB: 33.49 )
Ranked among companies with meaningful PFCF only.
MLAB' s PFCF Range Over the Past 10 Years
Min: 11.58  Med: 22.79 Max: 355.71
Current: 33.49
11.58
355.71
POCF 18.94
MLAB's POCF is ranked lower than
59% of the 205 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.81 vs. MLAB: 18.94 )
Ranked among companies with meaningful POCF only.
MLAB' s POCF Range Over the Past 10 Years
Min: 9.94  Med: 15.80 Max: 32.54
Current: 18.94
9.94
32.54
EV-to-EBIT 23.36
MLAB's EV-to-EBIT is ranked lower than
64% of the 208 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.49 vs. MLAB: 23.36 )
Ranked among companies with meaningful EV-to-EBIT only.
MLAB' s EV-to-EBIT Range Over the Past 10 Years
Min: 5.4  Med: 11.10 Max: 32.1
Current: 23.36
5.4
32.1
EV-to-EBITDA 16.25
MLAB's EV-to-EBITDA is ranked lower than
55% of the 227 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 14.89 vs. MLAB: 16.25 )
Ranked among companies with meaningful EV-to-EBITDA only.
MLAB' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.9  Med: 10.05 Max: 22.5
Current: 16.25
4.9
22.5
PEG 2.25
MLAB's PEG is ranked higher than
60% of the 63 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.97 vs. MLAB: 2.25 )
Ranked among companies with meaningful PEG only.
MLAB' s PEG Range Over the Past 10 Years
Min: 0.44  Med: 1.31 Max: 3.94
Current: 2.25
0.44
3.94
Shiller P/E 41.30
MLAB's Shiller P/E is ranked lower than
69% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 37.26 vs. MLAB: 41.30 )
Ranked among companies with meaningful Shiller P/E only.
MLAB' s Shiller P/E Range Over the Past 10 Years
Min: 16.04  Med: 28.04 Max: 58.58
Current: 41.3
16.04
58.58
Current Ratio 1.47
MLAB's Current Ratio is ranked lower than
77% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.65 vs. MLAB: 1.47 )
Ranked among companies with meaningful Current Ratio only.
MLAB' s Current Ratio Range Over the Past 10 Years
Min: 1.47  Med: 11.70 Max: 20.29
Current: 1.47
1.47
20.29
Quick Ratio 0.91
MLAB's Quick Ratio is ranked lower than
79% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. MLAB: 0.91 )
Ranked among companies with meaningful Quick Ratio only.
MLAB' s Quick Ratio Range Over the Past 10 Years
Min: 0.91  Med: 8.48 Max: 16
Current: 0.91
0.91
16
Days Inventory 158.00
MLAB's Days Inventory is ranked lower than
63% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 131.52 vs. MLAB: 158.00 )
Ranked among companies with meaningful Days Inventory only.
MLAB' s Days Inventory Range Over the Past 10 Years
Min: 104  Med: 147.48 Max: 201.41
Current: 158
104
201.41
Days Sales Outstanding 61.83
MLAB's Days Sales Outstanding is ranked higher than
56% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 64.05 vs. MLAB: 61.83 )
Ranked among companies with meaningful Days Sales Outstanding only.
MLAB' s Days Sales Outstanding Range Over the Past 10 Years
Min: 59.76  Med: 72.66 Max: 81.01
Current: 61.83
59.76
81.01
Days Payable 36.56
MLAB's Days Payable is ranked lower than
73% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 55.85 vs. MLAB: 36.56 )
Ranked among companies with meaningful Days Payable only.
MLAB' s Days Payable Range Over the Past 10 Years
Min: 9.42  Med: 19.03 Max: 35.03
Current: 36.56
9.42
35.03

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.78
MLAB's Dividend Yield is ranked lower than
79% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.43 vs. MLAB: 0.78 )
Ranked among companies with meaningful Dividend Yield only.
MLAB' s Dividend Yield Range Over the Past 10 Years
Min: 0.54  Med: 1.48 Max: 2.6
Current: 0.78
0.54
2.6
Dividend Payout 0.27
MLAB's Dividend Payout is ranked higher than
71% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.36 vs. MLAB: 0.27 )
Ranked among companies with meaningful Dividend Payout only.
MLAB' s Dividend Payout Range Over the Past 10 Years
Min: 0.16  Med: 0.26 Max: 0.35
Current: 0.27
0.16
0.35
Dividend Growth (3y) 7.40
MLAB's Dividend Growth (3y) is ranked lower than
59% of the 54 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.20 vs. MLAB: 7.40 )
Ranked among companies with meaningful Dividend Growth (3y) only.
MLAB' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 7.40 Max: 44.2
Current: 7.4
0
44.2
Forward Dividend Yield 0.78
MLAB's Forward Dividend Yield is ranked lower than
79% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.43 vs. MLAB: 0.78 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 1.15
MLAB's Yield on cost (5-Year) is ranked lower than
70% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. MLAB: 1.15 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
MLAB' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.8  Med: 2.18 Max: 3.84
Current: 1.15
0.8
3.84
3-Year Average Share Buyback Ratio -1.80
MLAB's 3-Year Average Share Buyback Ratio is ranked higher than
57% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.00 vs. MLAB: -1.80 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MLAB' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -2.9  Med: -0.50 Max: 6.1
Current: -1.8
-2.9
6.1

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.61
MLAB's Price/Projected FCF is ranked higher than
50% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. MLAB: 1.61 )
Ranked among companies with meaningful Price/Projected FCF only.
MLAB' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.51  Med: 1.29 Max: 2.5
Current: 1.61
0.51
2.5
Price/DCF (Earnings Based) 1.95
MLAB's Price/DCF (Earnings Based) is ranked higher than
51% of the 41 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.95 vs. MLAB: 1.95 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.02
MLAB's Price/Median PS Value is ranked higher than
51% of the 256 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.02 vs. MLAB: 1.02 )
Ranked among companies with meaningful Price/Median PS Value only.
MLAB' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.48  Med: 0.90 Max: 1.58
Current: 1.02
0.48
1.58
Price/Peter Lynch Fair Value 2.85
MLAB's Price/Peter Lynch Fair Value is ranked lower than
74% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.90 vs. MLAB: 2.85 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
MLAB' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.46  Med: 1.32 Max: 3.86
Current: 2.85
0.46
3.86
Earnings Yield (Greenblatt) (%) 4.30
MLAB's Earnings Yield (Greenblatt) (%) is ranked higher than
66% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. MLAB: 4.30 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MLAB' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 3.1  Med: 9.00 Max: 18.7
Current: 4.3
3.1
18.7
Forward Rate of Return (Yacktman) (%) 15.54
MLAB's Forward Rate of Return (Yacktman) (%) is ranked higher than
73% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.84 vs. MLAB: 15.54 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MLAB' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 9.8  Med: 18.70 Max: 29
Current: 15.54
9.8
29

More Statistics

Revenue(Mil) $78
EPS $ 2.35
Beta0.61
Short Percentage of Float6.13%
52-Week Range $67.70 - 126.05
Shares Outstanding(Mil)3.63

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Mesa Laboratories Inc was incorporated under the laws of the State of Colorado on March 26, 1982. The Company is focused on quality control products, which are sold into niche markets that are driven by regulatory requirements. It is organized into three divisions across six physical locations. Instruments Division designs, manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, environmental air sampling and semiconductor industries. Biological Indicators Division manufactures and markets biological indicators and distributes chemical indicators used to assess the effectiveness of sterilization processes, including steam, hydrogen peroxide, ethylene oxide and radiation, in the hospital, dental, medical device and pharmaceutical industries. Continuous Monitoring Division designs, develops and markets systems which are used to monitor various environmental parameters such as temperature, humidity and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies and a number of other laboratory and industrial environments. The Lakewood, Colorado, and Butler, New Jersey, facilities manufacture Instruments Division products which include the DataTrace, DialyGuard, DryCal, Torqo, SureTorque and BGI brands. The Omaha, Nebraska, and Bozeman, Montana locations manufacture Biological Indicators Division products which include the Mesa, PCD and Apex brands, while the Lakewood, Colorado, facility also manufactures Continuous Monitoring Division products which include CheckPoint and AmegaView brands. Companies with which Instruments Division products compete include the Myron L Company, IBP Medical GmbH, Amphenol Corporation, Ellab, TMI Orion, Danaher, Inc., Thermo Fisher Scientific, Inc., Mecmesin, Steinfurth, Met One Instruments, Inc. and Tisch Environmental. Biological Indicators Division products compete with 3M, Terragene, NAMSA and Steris, among others. Continuous Monitoring Division systems compete with Rees Scientific Corporation, Amphenol Corporation and Cooper-Atkins, among others. Several products in both the Instruments and Biological Indicators Divisions are medical devices subject to the provisions of the Federal Food, Drug and Cosmetic Act, as amended by the Medical Device Amendments of 1976.
» More Articles for MLAB

Headlines

Articles On GuruFocus.com
Van Den Berg Adds Four Stakes to Portfolio in Second Quarter Jul 14 2015 
Mesa Laboratories Inc. (MLAB) CFO, Secretary Steven W Peterson sells 10,000 Shares Mar 03 2011 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Nov 15 2010 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Aug 16 2010 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Feb 16 2010 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Nov 16 2009 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Aug 14 2009 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Feb 13 2009 

More From Other Websites
MESA LABORATORIES INC /CO Financials Feb 09 2016
6 Medical Device Stocks to Treat the Bear Market Blues Feb 08 2016
MESA LABORATORIES INC /CO Files SEC form 10-Q, Quarterly Report Feb 04 2016
Mesa Labs posts 3Q profit Feb 02 2016
Mesa Labs posts 3Q profit Feb 02 2016
MESA LABORATORIES INC /CO Files SEC form 8-K, Results of Operations and Financial Condition Feb 02 2016
Mesa Labs Reports Record Third Quarter Revenues and Adjusted Net Income Feb 02 2016
Mesa Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : February 1, 2016 Feb 01 2016
This Stock Gobbled Up Two Other Companies Last Year: 2016 Could Be the Year the Tables Turn Jan 20 2016
Mesa Labs Declares Quarterly Dividend Jan 05 2016
Mesa Labs Declares Quarterly Dividend Jan 05 2016
Mesa Labs Acquires Additional European Distribution Rights for its Biological Indicators Division Jan 04 2016
MESA LABORATORIES INC /CO Files SEC form 8-K, Other Events Jan 04 2016
Mesa Labs Acquires Additional European Distribution Rights for Its Biological Indicators Division Jan 04 2016
Mesa Laboratories, Inc. breached its 50 day moving average in a Bearish Manner : November 10, 2015 Nov 10 2015
MESA LABORATORIES INC /CO Files SEC form 10-Q, Quarterly Report Nov 04 2015
Mesa Labs Reports Record Second Quarter Revenues Nov 02 2015
Mesa Labs posts 2Q profit Nov 02 2015
Mesa Labs posts 2Q profit Nov 02 2015
MESA LABORATORIES INC /CO Files SEC form 8-K, Results of Operations and Financial Condition Nov 02 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK